ELAVL1 and hepatocellular carcinoma: The significance of blocking HuR SUMOylation was eventually verified in vivo by generating xenograft tumors via the subcutaneous injection of the HuH-7 human hepatoma cell line stably expressing the WT and K120/182R HuR variants in each flank of NOD scid gamma (NSG) mice (n = 6).